Sign inJoin waitlistJoin the waitlist

EM

Eric McDade

Professor of Neurology, DIAN-TU · Washington University/B-JH/SLCH Consortium

Credentials: · · · · ·

History

Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present

Neurology
2004–2007
Chicago College of Osteopathic Medicine
2000–2004

Research

Clinical and biomarker changes in dominantly inherited Alzheimer's disease
New England Journal of Medicine · 2012 · 3,051 citations
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Alzheimer s & Dementia · 2024 · 2,230 citations
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Nature Medicine · 2019 · 718 citations

Randall Bateman
150 papers
John Morris
116 papers
Tammie Benzinger
108 papers
Jasmeer Chhatwal
77 papers
Richard Perrin
66 papers
SB
Sarah Berman
53 papers
Martin Farlow
52 papers
Stephen Salloway
52 papers
Gregory Day
50 papers
Clifford Jack
46 papers
John Ringman
43 papers
Bernardino Ghetti
36 papers

Grants

Dominantly Inherited Alzheimer Network
National Institute on Aging · U19
Contact PI · $9.6M · Washington University
2026–2031
DIAN-TU Primary Prevention Trial
National Institute on Aging · R01
Contact PI · $2.2M · Washington University
2018–2031
Multidisciplinary Training in Alzheimer and Related Dementias
National Institute on Aging · T32
PI · $1.3M · Washington University
2018–2029
Bridge Funding for Dominantly Inherited Alzheimer Network
National Institute on Aging · U19
Contact PI · $5.6M · Washington University
2008–2026

Clinical trials

Dominantly Inherited Alzheimer Network (DIAN)
Principal investigator · Recruiting
Washington University School of Medicine
2009–2026
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Study director · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Study director · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034